This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Bioservo Technologies Past Earnings Performance
Past criteria checks 0/6
Bioservo Technologies's earnings have been declining at an average annual rate of -15.8%, while the Medical Equipment industry saw earnings growing at 6.5% annually. Revenues have been declining at an average rate of 11.8% per year.
How Bioservo Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
OM:BIOS Revenue, expenses and earnings (SEK Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
30 Sep 23
12
-47
47
0
30 Jun 23
11
-48
49
0
31 Mar 23
15
-48
52
0
31 Dec 22
14
-50
54
0
30 Sep 22
15
-43
48
0
30 Jun 22
17
-39
44
0
31 Mar 22
13
-38
41
0
31 Dec 21
11
-35
36
0
30 Sep 21
7
-34
36
0
30 Jun 21
5
-34
35
0
31 Mar 21
10
-28
32
0
31 Dec 20
14
-26
34
0
30 Sep 20
22
-25
37
0
30 Jun 20
23
-24
39
0
31 Mar 20
25
-25
42
0
31 Dec 19
24
-23
40
0
30 Sep 19
23
-27
37
0
30 Jun 19
21
-28
36
0
31 Mar 19
17
-27
33
0
31 Dec 18
16
-28
31
0
30 Sep 18
15
-23
31
0
30 Jun 18
14
-21
28
0
31 Mar 18
12
-22
27
0
31 Dec 17
12
-19
25
0
30 Sep 17
11
-17
24
0
30 Jun 17
11
-16
22
0
31 Mar 17
12
-12
20
0
31 Dec 16
11
-13
20
0
31 Dec 15
11
-7
16
0
31 Dec 14
8
-4
12
0
Quality Earnings: BIOS is currently unprofitable.
Growing Profit Margin: BIOS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BIOS is unprofitable, and losses have increased over the past 5 years at a rate of 15.8% per year.
Accelerating Growth: Unable to compare BIOS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BIOS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-10.8%).
Return on Equity
High ROE: BIOS has a negative Return on Equity (-121.81%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2024/01/12 17:49
End of Day Share Price
2024/01/12 00:00
Earnings
2023/09/30
Annual Earnings
2022/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bioservo Technologies AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.